Volume 65, Issue 3, Pages (September 2016)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Volume 42, Issue 5, Pages (May 2005)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 67, Issue 3, Pages (September 2017)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Volume 59, Issue 6, Pages (December 2013)

Global trends and predictions in hepatocellular carcinoma mortality

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: Cohort study using the General Practice Research Database

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 66, Issue 1, Pages 1-4 (January 2017)

Volume 69, Issue 1, Pages (July 2018)

Living donor liver transplantation: is the hype over?

European Association for the Study of the Liver Journal of Hepatology

Volume 69, Issue 2, Pages (August 2018)

The place of downstaging for hepatocellular carcinoma

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

European Association for the Study of the Liver Journal of Hepatology

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok

Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis Pilar Brito-Zerón, MD, PhD, Belchin Kostov,

Volume 57, Issue 5, Pages (November 2012)

Volume 70, Issue 3, Pages (March 2019)

Volume 63, Issue 2, Pages (August 2015)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers

Volume 41, Issue 3, Pages (September 2004)

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 64, Issue 6, Pages (June 2016)

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

EASL Clinical Practice Guidelines: Drug-induced liver injury

Volume 66, Issue 3, Pages (March 2017)

Volume 62, Issue 3, Pages (March 2015)

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Donor-recipient matching: Myths and realities

Chimeric mouse model of hepatitis B virus infection

Volume 44, Issue 1, Pages (January 2006)

Volume 44, Issue 4, Pages (April 2006)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Presentation transcript:

Volume 65, Issue 3, Pages 532-542 (September 2016) Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury Inmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, Camilla Stephens, Aida Ortega-Alonso, Miren Garcia-Cortes, Andres González-Jimenez, Judith A. Sanabria-Cabrera, Inmaculada Moreno, M. Carmen Fernandez, Manuel Romero-Gomez, Jose M. Navarro, Ana Mª Barriocanal, Eva Montane, Hacibe Hallal, Sonia Blanco, German Soriano, Eva M. Roman, Elena Gómez-Dominguez, Agustin Castiella, Eva M. Zapata, Miguel Jimenez-Perez, Jose M. Moreno, Ana Aldea-Perona, Manuel Hernández-Guerra, Martin Prieto, Miguel E. Zoubek, Neil Kaplowitz, M. Isabel Lucena, Raul J. Andrade Journal of Hepatology Volume 65, Issue 3, Pages 532-542 (September 2016) DOI: 10.1016/j.jhep.2016.05.003 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Flow chart of the study cohort. Journal of Hepatology 2016 65, 532-542DOI: (10.1016/j.jhep.2016.05.003) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Time to liver injury resolution in 285 patients with acute idiosyncratic drug-induced liver injury who recovered classified by type of damage. An additional 13 patients (not included) had not recovered after 3years. Chol, cholestatic; HC, hepatocellular; Mix, mixed. Journal of Hepatology 2016 65, 532-542DOI: (10.1016/j.jhep.2016.05.003) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Median of ALP, ALT and TB values during the first year from DILI onset in acute and chronic groups. Each time interval includes 15days. Journal of Hepatology 2016 65, 532-542DOI: (10.1016/j.jhep.2016.05.003) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2016 65, 532-542DOI: (10. 1016/j. jhep. 2016. 05 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions